Issue 13, 2021

B-Doped core–shell Fe@BC nanozymes: active site identification and bacterial inhibition

Abstract

The rational design of nanozymes as new “antibiotics” for bacterial therapy is a promising area in healthcare. Herein, B-doped core–shell Fe@BC nanozymes functioned with peroxidase-like activity for bacterial inhibition were studied. Experimental and theoretical results show that the BCO2 site enables a much lower energy barrier than the BC2O site, with a positive correlation between the density and activity of BCO2. The enzyme-like and positively-charged properties of core–shell Fe@BC improve the production and utilization of ˙OH to efficiently kill bacteria. This study not only highlights a promising peroxidase mimic for hygiene management but also deepens the understanding of B-doped carbon nanozymes.

Graphical abstract: B-Doped core–shell Fe@BC nanozymes: active site identification and bacterial inhibition

Supplementary files

Article information

Article type
Communication
Submitted
07 Oct 2020
Accepted
29 Dec 2020
First published
29 Dec 2020

Chem. Commun., 2021,57, 1623-1626

B-Doped core–shell Fe@BC nanozymes: active site identification and bacterial inhibition

X. Jiang, K. Liu, Q. Li, M. Liu, M. Yang and X. Chen, Chem. Commun., 2021, 57, 1623 DOI: 10.1039/D0CC06692C

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements